Literature DB >> 28985243

Conducting and reporting trials for older people.

Miles D Witham1, David J Stott2.   

Abstract

Randomised controlled trials provide the most rigorous test of efficacy and effectiveness for interventions used in healthcare. They underpin much of clinical practice, yet older people are often excluded from studies, resulting in uncertainty about risks and benefits of new treatments. Encouraging inclusion of older people in randomised controlled trials and reporting of trial results in a rigorous manner is a key function of clinical geriatrics journals such as Age and Ageing. This article provides practical advice on how to report randomised controlled trials that are targeted at older people. Some of these issues are generic, but there are specific requirements which apply to most studies of older people. Recording and reporting basic characteristics of recruits in terms of physical function, cognition, comorbidity and/or frailty is vital to allow proper interpretation of the external validity of the trial. Adverse effects should include consideration of common geriatric problems including falls. Authors should follow the CONSORT reporting guidelines (CONsolidated Standards Of Reporting Trials) to enhance the transparency and quality of their manuscript.
© The Author 2017. Published by Oxford University Press on behalf of the British Geriatrics Society.All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Research methods; older people; randomised controlled trials

Mesh:

Year:  2017        PMID: 28985243     DOI: 10.1093/ageing/afx153

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  6 in total

1.  Sodium bicarbonate to improve physical function in patients over 60 years with advanced chronic kidney disease: the BiCARB RCT.

Authors:  Miles D Witham; Margaret Band; Huey Chong; Peter T Donnan; Geeta Hampson; May Khei Hu; Roberta Littleford; Edmund Lamb; Philip A Kalra; Gwen Kennedy; Paul McNamee; Deirdre Plews; Petra Rauchhaus; Roy L Soiza; Deepa Sumukadas; Graham Warwick; Alison Avenell
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

2.  Pre-frail older adults show improved cognition with StayFitLonger computerized home-based training: a randomized controlled trial.

Authors:  Sylvie Belleville; M Cuesta; M Bieler-Aeschlimann; K Giacomino; A Widmer; A G Mittaz Hager; D Perez-Marcos; S Cardin; B Boller; N Bier; M Aubertin-Leheudre; L Bherer; N Berryman; S Agrigoroaei; J F Demonet
Journal:  Geroscience       Date:  2022-10-21       Impact factor: 7.581

3.  Use of robot technology in passive mobilization of acute hospitalized geriatric medicine patients: a pilot test and feasibility study.

Authors:  A S Bertelsen; A Storm; L Minet; J Ryg
Journal:  Pilot Feasibility Stud       Date:  2020-01-06

4.  Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males.

Authors:  Mieke Van Hemelrijck; Eugenio Ventimiglia; David Robinson; Rolf Gedeborg; Lars Holmberg; Pär Stattin; Hans Garmo
Journal:  BMC Med Inform Decis Mak       Date:  2022-02-08       Impact factor: 2.796

5.  Effects of treadmill slip and trip perturbation-based balance training on falls in community-dwelling older adults (STABILITY): study protocol for a randomised controlled trial.

Authors:  Jens Eg Nørgaard; Stig Andersen; Jesper Ryg; Andrew James Thomas Stevenson; Jane Andreasen; Mathias Brix Danielsen; Anderson de Souza Castelo Oliveira; Martin Grønbech Jørgensen
Journal:  BMJ Open       Date:  2022-02-07       Impact factor: 2.692

6.  Exercise for people living with frailty and receiving haemodialysis: a mixed-methods randomised controlled feasibility study.

Authors:  Hannah M L Young; Daniel S March; Patrick J Highton; Matthew P M Graham-Brown; Darren C Churchward; Charlotte Grantham; Samantha Goodliffe; William Jones; Mei-Mei Cheung; Sharlene A Greenwood; Helen C Eborall; Simon Conroy; Sally J Singh; Alice C Smith; James O Burton
Journal:  BMJ Open       Date:  2020-11-03       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.